UK markets closed

cbdMD, Inc. (YCBD)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
2.58000.0000 (0.00%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.5800
Open2.5700
Bid2.5700 x 800
Ask2.6500 x 27000
Day's range2.5500 - 2.6400
52-week range1.7600 - 6.8300
Volume124,276
Avg. volume245,784
Market cap146.976M
Beta (5Y monthly)1.76
PE ratio (TTM)N/A
EPS (TTM)-0.7260
Earnings date10 Aug 2021 - 16 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.42
  • cbdMD Enters into Letter of Intent To Purchase DirectCBDOnline.com
    Business Wire

    cbdMD Enters into Letter of Intent To Purchase DirectCBDOnline.com

    CHARLOTTE, N.C., July 19, 2021--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that it has entered into a letter of intent to purchase leading CBD online marketplace, DirectCBDOnline.com, from Twenty Two Capital, LLC.

  • cbdMD Therapeutics Releases Research Plan
    Business Wire

    cbdMD Therapeutics Releases Research Plan

    CHARLOTTE, N.C., July 08, 2021--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. The Company also anticipates the identification of dietary supplement applications through this process. The Company expects to finalize the agreeme

  • cbdMD, Inc. Announces Closing of Underwritten Public Offering of 8.0% Series A Cumulative Convertible Preferred Stock and Full Exercise of Underwriter’s Over-allotment Option for Total Gross Proceeds of $16.5 Million
    Business Wire

    cbdMD, Inc. Announces Closing of Underwritten Public Offering of 8.0% Series A Cumulative Convertible Preferred Stock and Full Exercise of Underwriter’s Over-allotment Option for Total Gross Proceeds of $16.5 Million

    CHARLOTTE, N.C., July 01, 2021--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), today announced the closing of its previously announced underwritten public offering for total gross proceeds of $16,500,000, before deducting underwriting discounts, commissions, and other offering expenses payable by the company. cbdMD, Inc. sold an aggregate of 2,200,000 shares of its 8.0% Series A Cumulative Convertible Preferred Stock, which includes 286,900 shares sold upon full exercise of the over-allotment option